June is Cataract Awareness Month - click here for FREE healthy vision tips
Glaucoma is a group of eye conditions that damage the optic nerve, the health of which is vital for good vision. This damage is often caused by an abnormally high pressure in your eye. Glaucoma is one of the leading causes of blindness for people over the age of 60.
1% N-acetylcarnosine Can-C eye drops™
Healthy eyes contain high levels of the natural antioxidant L-Carnosine. Interestingly, the eyes of those suffering from degenerative ocular diseases such as Glaucoma were found to be highly deficient in L-Carnosine. Can-C™ Eye Drops contain N-acetyl-carnosine (NAC) that metabolizes into L-Carnosine in the eye, re-establishing youthful L-Carnosine levels to help counter oxidative stress and improve eye pressure management, providing targeted support for those who suffer from Glaucoma.
The prime ingredient in Can-C™ is a proprietary form of N-Acetyl-Carnosine (NAC), which acts as both a stabilizer and carrier for L-Carnosine, safely delivering it into the fluid area of the eye surrounding the lens, allowing Carnosine to access the areas it needs to in order to act as a natural and highly effective antioxidant that protects and heals the eye from Glaucoma and other ocular disease.
In clinical trials, Can-C™ eye drops applied daily were shown to reverse protein aggregation (oxidation) and inflammation in the majority of subjects thereby allowing the eyes’ natural repair mechanisms to address the causative factors of most ocular conditions such as eye pressure management and cataract.
N-alpha-Acetylcarnosine is proposed for treatment of ocular disorders that have a component of oxidative stress in their genesis (glaucoma, cataracts, retinal degeneration, ocular inflammation…)
“The advantage of N-alpha-acetylcarnosine and its bioactivated principle L-carnosine as universal antioxidants relates to their ability to give efficient protection against oxidative stress both in the lipid phase of biological membranes and in aqueous environments.”
1% N-acetylcarnosine Can-C eye drops™ + Nac-C Plus Capsules
For those looking to impede the progression of and ultimately reverse vision loss from glaucoma.
Molecular biologist Dr. Mark Babizhayevs’ groundbreaking research demonstrated that N-Acetylcarnosine (NAC) is effective when applied to the eyes via drops to reverse the oxidation buildup causing Glaucoma progression and eye pressure elevation.
Independent Study finds specific Amino Acids and Anti-Oxidants provide targeted support for those who suffer from IOP and Glaucoma. The independent study below notes that effectively reducing or even reversing oxidation may facilitate a healing response in the trabecular meshwork or outflow pathway in the eyes of glaucoma patients, a key suspect in the progression of POAG is local oxidative stress. Oxidative free radicals and reactive oxygen species (ROS) are reported to trigger degeneration in the trabecular meshwork, subsequently leading to increases in IOP and glaucoma.
The study provides evidence that mitochondrial dysfunction is a possible mechanism for the loss of trabecular meshwork cells in POAG. They also report that the antioxidants vitamin E and n-acetyl cysteine (NAC), can reduce the progression of Glaucoma. Reversing oxidation may be protective of and facilitate a healing response in the trabecular mesh-work or outflow pathway in the eyes of glaucoma patients.
Mitochondrial complex I defect induces ROS release and degeneration in trabecular meshwork cells of POAG patients: protection by antioxidants
There is growing evidence that oxidative stress contributes to the progression of primary open-angle glaucoma (POAG).
Can-C eye drops™ + Nac-C Plus Capsules + ARMeD Capsules
For those with advanced glaucoma or multiple degenerative eye conditions.
Dr. Walter Pierpaoli’s Bonded Melatonin Formula ARMeD™ contains a unique Melatonin, from organic, pharmaceutical-grade, plant-based ingredients, bonded with Selenium and Zinc. Additionally, Dr. Pierpaoli and his colleagues included critical excipients which work with the melatonin in regulating fundamental immunological hormone functions to a much greater degree.
The study authors stated “Melatonin has been shown to have the capacity to control eye pigmentation and thereby regulate the amount of light reaching the photoreceptors, to scavenge hydroxyradicals and to protect retinal pigment epithelium (RPE) cells from oxidative damage. Therefore, it is reasonable to think that the physiological decrease of melatonin in aged people may be an important factor in RPE dysfunction“
This powerful bonded Melatonin formula works to protect the eyes from Glaucoma via three distinct pathways:
The use of Melatonin in the treatment of eye disease was the subject of the Stromboli conferences in Italy. This study was published by the NY Academy of Sciences. “Please do not fail to recommend Dr. Walter Pierpaoli’s bonded Melatonin formula, as there is virtually no downside and tremendous benefits of for the correct Melatonin application which are well documented and far reaching.” Gary F. Gordon MD,DO,MD(H) – President, Gordon Research Institute
Please note that ARMeD™ is quite distinct from the sublingual and time-released versions of melatonin as they have a preset time of release which does not mirror the body’s natural circadian rhythm. ARMeD™ actually mimics nature by improving upon the body’s own natural night peak release of melatonin and the results of this superior action speak for themselves.By preventing cell damage
Melatonin in the eye: implications for glaucoma
“Melatonin, being an efficient antioxidant with antinitridergic properties, has a promising role in the treatment and management of glaucoma.”
Protective effects of melatonin in experimental free radical-related ocular diseases
“Current evidence suggests that melatonin may act as a protective agent in ocular conditions such as photo-keratitis, cataract, glaucoma and retinopathy.”
Role of melatonin in the eye and ocular dysfunctions
“Melatonin is an effective antioxidant which scavenges free radicals and up-regulates several antioxidant enzymes. Melatonin cytoprotective properties may have practical implications in the treatment of ocular diseases, like glaucoma and age-related macular degeneration”
Melatonin Metabolites Protect Human Retinal Pigment Epithelial Cells from Death Caused by Oxidative Stress
“It was concluded that these melatonin metabolites might be useful in treating many retinal conditions linked to the oxidative stress-induced damage.”